IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 21 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,404 | +203572.7% | 7,569 | +103.7% | 0.00% | – |
| Q1 2023 | $11 | -15.4% | 3,716 | +52.8% | 0.00% | -100.0% |
| Q4 2022 | $13 | -99.9% | 2,432 | -8.6% | 0.00% | – |
| Q3 2022 | $11,000 | – | 2,661 | +88600.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 3 | -97.5% | 0.00% | – |
| Q4 2021 | $1,000 | -98.4% | 119 | -98.8% | 0.00% | -100.0% |
| Q3 2021 | $61,000 | +454.5% | 9,846 | +450.1% | 0.00% | – |
| Q2 2021 | $11,000 | +120.0% | 1,790 | +461.1% | 0.00% | – |
| Q4 2020 | $5,000 | – | 319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
| Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
| Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
| Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
| IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 7 | $0 | 0.00% |
| MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |